BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  CytoSorbents Receives $676,739 in Non-Dilutive Funding From the New Jersey Technology Business Tax Certificate Transfer Program

  CytoSorbents announced the receipt of $676,739, net of transaction costs, in non-dilutive funding as an approved participant of the Technology Business Tax Certificate Transfer Program sponsored by the NJEDA.

  December 19, 2017

   · 

  5 min read
• Drug Development

  Critical Outcome Technologies Announces Pharmacodynamic Data and Positive Signals of Efficacy from Phase I Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies

  Critical Outcome Technologies announced pharmacodynamic (PD) data and positive signals of efficacy from the dose-escalation portion of its Phase 1 trial of COTI-2 in gynecological malignancies that support the continued development of COTI-2 as a potential treatment for patients.

  December 19, 2017

   · 

  8 min read
• Business

  ClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma to Develop Staphylococcus Aureus Vaccine With Boston Children’s Hospital

  ClearPath announced today it has initiated a third research collaboration with Astellas Pharma to combat infections.

  December 19, 2017

   · 

  4 min read
• Deals

  BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

  The acquisition fortifies BiomX’s bacterial target discovery capabilities and supports its product development pipeline.

  December 19, 2017

   · 

  2 min read
• Avista Pharma Solutions Expands Drug Product cGMP Manufacturing at Colorado Site

  Avista has completed extensive facility upgrades at its Longmont, Colorado site, expanding its drug product manufacturing footprint by approximately 20,000 square feet and allowing for the formulation and manufacture of new dosage forms.

  December 19, 2017

   · 

  3 min read
• Business

  Pfenex Earns $18.5M in Milestones and Updates Worldwide License and Option Agreement With Jazz Pharma

  Pfenex today announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharma worldwide rights to develop and commercialize multiple early stage hematology product candidates.

  December 19, 2017

   · 

  5 min read
• 

  Business

  Pfizer Strikes Deal With Array BioPharma on Anti-Cancer Development

  Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations.

  December 19, 2017

   · 

  8 min read
• Drug Development

  Second Genome Advances Lead, Oral Small Molecule SGM-1019, Toward Clinical Investigation in NASH After Demonstrating Safety and Tolerability in Phase I Study

  Second Genome announced today it has successfully completed a Phase 1 study in healthy volunteers for its lead therapeutic candidate, SGM-1019.

  December 19, 2017

   · 

  3 min read
• Business

  J&J to Host Investor Conference Call on Fourth-Quarter Results

  J&J will host a conference call for investors at 8:30 a.m. on Tuesday, January 23rd, to review fourth-quarter results.

  December 19, 2017

   · 

  1 min read
• Deals

  Pace Analytical Life Sciences and Wolfe Laboratories Join Forces to Provide Expanded Contract Drug Development Services and Analytics to the Life Science Industry

  Financial terms of the transaction were not disclosed.

  December 19, 2017

   · 

  3 min read